Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Carcinoma, Ovarian Epithelial; Ovarian Neoplasms Phase 2 ClinicalTrials
Myelodysplastic Syndromes; Preleukemia; Syndrome Phase 2 ClinicalTrials
CONTENTS